What an interesting result. Paxlovid really helped this 64 year old woman with her COVID-19. Looking at the long Covid data, I hope the FDA liberalizes access to Paxlovid for middle aged adults soon.

Expand full comment

"Nasty table"?? I suspect you mean hasty (I hope).

Good news that reduction through both vaccination and COVID-19 Tx helps to reduce the incidence of PASC. However, as a Tx for PASC, this remains to be seen as this is a rather complicated issue. Of course, we need to do the science on it. If there is any consolation, many do recover by year's time. (Wish I can find that study).

Nice to see a note of Natural History of ID. Many things that happens in COVID-19 is not unique to SARS.Cov2. Seems that the pandemic shined a spotlight on things that were always there. I lost my hearing as a result of measles at 13 months. Do we call it Long Measles? ;)

Expand full comment

Perhaps the greater rate of reporting long covid in younger people is because symptoms are more obvious when you don't have all kinds of other aches and pains - like painting on a blank canvas.😆

There's also the pitfall (?) in older age of attributing everything thing to aging, or perhaps we become more accepting of imperfection as we grow!

Expand full comment